Cognition, Cognitive Dysfunction, and Cognitive Rehabilitation in Multiple Sclerosis

Pepping, Mary; Brunings, Julie; Goldberg, Michael A.

doi:10.1016/j.pmr.2013.06.009

Cited by 14 publications

(9 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many studies have revealed that an early treatment of MS and a speech rehabilitation therapy in MS patients with speech disorders can significantly help in controlling the progressive alteration in the intelligibility of the speech capacity [120][121][122] .…”

Section: Speech Disordersmentioning

confidence: 99%

Otolaryngologic Symptoms in Multiple Sclerosis: A Review

Ralli¹,

Stadio²,

Visconti³

et al. 2018

The International Tinnitus Journal

View full text Add to dashboard Cite

Many symptoms of multiple sclerosis may affect the ear, nose and throat. The most common otolaryngologic symptoms of multiple sclerosis are speech disorders, followed by sleep disorders, vertigo and disequilibrium, dysphagia, smell alterations, and hearing loss. Less common symptoms include sialorrhea, facial palsy, taste alterations, trigeminal neuralgia and tinnitus. The origin of otolaryngologic symptoms in multiple sclerosis is mainly central, although increasing evidence also suggests a peripheral involvement.

show abstract

Section: Speech Disordersmentioning

confidence: 99%

Otolaryngologic Symptoms in Multiple Sclerosis: A Review

Ralli¹,

Stadio²,

Visconti³

et al. 2018

The International Tinnitus Journal

View full text Add to dashboard Cite

show abstract

“…Executive deficits are among the first cognitive deficits to emerge with ageing (Hedden & Gabrieli, 2004) and a common occurrence in a variety of patient populations, including traumatic brain injury (TBI) (Kennedy et al, 2008), stroke (Chung, Pollock, Campbell, Durward, & Hagen, 2013), schizophrenia (Eisenberg & Berman, 2010), Attention Deficit Hyperactivity Disorder (ADHD) (T. E. Brown, 2008) and multiple sclerosis (MS) (Pepping, Brunings, & Goldberg, 2013). Despite distinct neuropathological processes, it is believed that the underlying mechanismthe disruptions of brain networks controlling executive deficitsis the same across populations.…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of goal management training® in improving executive functions: A meta-analysis

Stamenova

Levine

2018

Neuropsychological Rehabilitation

View full text Add to dashboard Cite

Our objective was to review the literature and quantitatively summarise the effectiveness of Goal Management Training® (GMT) (alone or in combination with other training approaches) in improving executive functions in adult populations. Ovid, Scopus, Web of Science, and ProQuest Dissertations & Theses Global were searched for articles citing "goal management training". Any group trials (n > 3) in adults that used multiple-session GMT programmes were included in the analyses. Outcome variables were extracted and classified into one of nine cognitive measures domains: executive functioning tasks, everyday executive functioning tasks, subjective executive tasks rated by the patient, subjective executive tasks rated by proxy, working memory, speed of processing, long-term memory, instrumental activities of daily living and general mental health status questionnaires. A total of 21 publications, containing 19 separate treatment group samples were included in the final analyses. Significantly positive small to moderate effect sizes were observed in all cognitive measure domains (except speed of processing) with effects maintained at follow-up assessments for all followed-up outcome measures, except for subjective ratings by patients and proxy. The analysis suggests that GMT is an effective intervention, leading to moderate improvements in executive functions that are usually maintained at follow-up.

show abstract

“…More recently, cooled wearable pads and garments have been successfully used as a method of combating increased heating in MS patients during exercise and maintaining motor function. 46 Renom et al, 2014, 48 Pepping et al, 2013, 47 Langdon, 2011, 45 DasGupta et al, 2003, 43 Buzaid et al, 2013, 42 Khan et al, 2015, 44 Svestkova et al, 2010, 49 National Clinical Guideline Centre, 2014. 41 …”

Section: Body Temperaturementioning

confidence: 99%

Neurorehabilitation in Multiple Sclerosis – Resilience in Practice

Kesselring¹

2017

European Neurological Review

View full text Add to dashboard Cite

In recent years, enormous strides have been made in increasing the range and efficacy of disease-modifying drugs available for the treatment of multiple sclerosis (MS) in its early and remitting stages, and more continue to emerge. Another equally important concept of successful treatment of MS is neurorehabilitation, which must be pursued alongside these medications. Key factors that contribute to the impact of neurorehabilitation include resilience and neuroplasticity. In the former, components such as nutrition, self-belief and physical activity provide a stronger response to the disease and improved responses to treatment. Neuroplasticity is the capacity of the brain to establish new neuronal networks after lesion damage has occurred and distant brain regions assume control of lost functions. In MS, it is vital that each patient is treated by a coordinated multidisciplinary team. This enables all aspects of the disease including problems with mobility, gait, bladder/bowel disturbances, fatigue and depression to be effectively treated. It is also important that the treating team adopts current best practice and provides internationally agreed standards of care. A further vital aspect of MS management is patient engagement, in which individuals are fully involved and are encouraged to strive and put effort into meeting treatment goals. In this approach, healthcare providers become motivators and patients need less intervention and consume fewer resources. Numerous interventions that promote neurorehabilitation are available, though evidence to support their use is limited by a lack of data from large randomised controlled trials. Combining interventions that promote neurorehabilitation with newer, more effective treatments creates a promising potential to substantially improve the outlook for patients at all stages of MS.

show abstract

Cognition, Cognitive Dysfunction, and Cognitive Rehabilitation in Multiple Sclerosis

Cited by 14 publications

References 35 publications

Otolaryngologic Symptoms in Multiple Sclerosis: A Review

Otolaryngologic Symptoms in Multiple Sclerosis: A Review

Effectiveness of goal management training® in improving executive functions: A meta-analysis

Neurorehabilitation in Multiple Sclerosis – Resilience in Practice

Contact Info

Product

Resources

About